What is Cohen & Steers Inc.'s earnings per share (EPS)?

Cohen & Steers Inc. (CNS) reported diluted earnings per share of $2.97 for fiscal year 2025. That is unchanged from the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Cohen & Steers Inc. (CNS) Financials

CNS

FY2025 annual

Revenue $556.1M +7.5% YoY

Net Income $153.2M +1.3% YoY

EPS (Diluted) $2.97 0.0% YoY

Free Cash Flow -$126.4M -248.7% YoY

Market Cap $3.7B as of Oct 6, 2026

Price / Sales 6.4x on $583.9M revenue, trailing 12 months to June 30, 2026

Price / Earnings 22.2x on $168.3M net income, trailing 12 months to June 30, 2026

Price / Book 6.3x on $589.4M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 6, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Jul 31, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Jul 31, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the CNS SEC filings page.

Cohen & Steers Inc. (CNS) reported $556.1M in revenue for fiscal year 2025, up 7.5% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI CNS FY2025 2026-10-03

Reported profit remains positive, but FY2025 exposed a sharp cash-conversion break despite a larger, less leveraged balance sheet.

The business converted $97M of operating cash from $151M of net income in FY2024, then reported operating cash flow of -$120M against $153M of net income in FY2025. That reversal means the latest earnings figure and cash generation are telling materially different stories, even though the reported profit margin remained positive at 27.6%.

The margin structure has gradually compressed: operating margin fell from 44.6% in FY2021 to 32.0% in FY2025 while revenue moved from $584M to $556M. Costs therefore absorbed a larger share of revenue over the period, rather than growth producing obvious operating leverage.

The balance sheet became less debt-dependent as total equity reached $562M and debt-to-equity declined to 0.4x in FY2025 from 0.6x in FY2021, while liabilities stayed near $243M. That combination suggests asset growth was funded more through accumulated equity than rising obligations, but the latest cash outflow weakens the quality of that improvement.

Financial Health Signals

Financial Health Score 39/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Cohen & Steers Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Cohen & Steers Inc. has an operating margin of 32.0%, meaning the company retains $32 of operating profit per $100 of revenue. This strong profitability earns a score of 93/100, reflecting efficient cost management and pricing power. This is down from 33.4% the prior year.

Growth

Cohen & Steers Inc.'s revenue grew 7.5% year-over-year to $556.1M, a solid pace of expansion. This earns a growth score of 56/100.

Leverage

Cohen & Steers Inc. has a moderate D/E ratio of 0.43. This balance of debt and equity financing earns a leverage score of 63/100.

Liquidity

Not available for Cohen & Steers Inc., and counted as zero in the overall score.

Cash Flow

Cohen & Steers Inc.'s operations used $120.4M of cash, and capex of $6.0M added to the outflow, for a free cash flow shortfall of $126.4M. This results in a cash flow score of 22/100.

Returns

Not available for Cohen & Steers Inc., and counted as zero in the overall score.

Piotroski F-Score Partial

1/6

Cohen & Steers Inc. passes 1 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.

Earnings Quality No Cash Backing

$0.79used

For every $1 of reported earnings, Cohen & Steers Inc. used $0.79 of operating cash (-$120.4M OCF vs $153.2M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$152.7M

YoY+12.2%

QoQ+4.9%

5Y CAGR+1.1%

10Y CAGR+5.9%

Cohen & Steers Inc. generated $152.7M in revenue in Q2 2026. This represents an increase of 12.2% from the same quarter a year earlier. Against the prior quarter it is up 4.9%.

EBITDA

$55.4M

YoY+21.2%

QoQ+5.1%

5Y CAGR-1.8%

Cohen & Steers Inc.'s EBITDA was $55.4M in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 21.2% from the same quarter a year earlier. Against the prior quarter it is up 5.1%.

Net Income

$49.3M

YoY+33.9%

QoQ+16.5%

5Y CAGR+1.2%

10Y CAGR+7.1%

Cohen & Steers Inc. reported $49.3M in net income in Q2 2026. This represents an increase of 33.9% from the same quarter a year earlier. Against the prior quarter it is up 16.5%.

EPS (Diluted)

$0.95

YoY+31.9%

QoQ+15.9%

5Y CAGR0.0%

10Y CAGR+6.0%

Cohen & Steers Inc. earned $0.95 per diluted share (EPS) in Q2 2026. This represents an increase of 31.9% from the same quarter a year earlier. Against the prior quarter it is up 15.9%.

Cash & Balance Sheet

Cash & Debt

$59.2M

YoY-38.0%

QoQ+11.4%

5Y CAGR-11.9%

10Y CAGR-8.3%

Cohen & Steers Inc. held $59.2M in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share

$0.67

YoY+8.1%

QoQ0.0%

5Y CAGR+8.3%

10Y CAGR+9.9%

Cohen & Steers Inc. paid $0.67 per share in dividends in Q2 2026. This represents an increase of 8.1% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding

51M

YoY+0.8%

QoQ0.0%

5Y CAGR+1.3%

10Y CAGR+1.1%

Cohen & Steers Inc. had 51M shares outstanding in Q2 2026. This represents an increase of 0.8% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q2 2026.

Margins & Returns

Operating Margin

34.5%

YoY+2.7pp

QoQ+0.1pp

5Y change-6.8pp

10Y change-5.0pp

Cohen & Steers Inc.'s operating margin was 34.5% in Q2 2026, reflecting core business profitability. This is up 2.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Net Margin

32.3%

YoY+5.2pp

QoQ+3.2pp

5Y change0.0pp

10Y change+3.6pp

Cohen & Steers Inc.'s net profit margin was 32.3% in Q2 2026, showing the share of revenue converted to profit. This is up 5.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 3.2 percentage points.

Return on Equity

8.4%

YoY+1.4pp

QoQ+0.8pp

5Y change-12.3pp

10Y change-1.3pp

Cohen & Steers Inc.'s ROE was 8.4% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 1.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.8 percentage points.

Gross Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks

$394K

YoY-36.6%

QoQ-97.7%

5Y CAGR+37.2%

10Y CAGR-3.5%

Cohen & Steers Inc. spent $394K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 36.6% from the same quarter a year earlier. Against the prior quarter it is down 97.7%.

R&D Spending

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

CNS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CNS quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$583.9M	$556.1M+7.5%	$517.4M+5.7%	$489.6M-13.6%	$566.9M-2.9%	$583.8M+36.6%	$427.5M+4.1%	$410.8M+7.8%	$381.1M+0.6%	$378.7M+8.2%	$349.9M+6.5%	$328.7M+4.7%	$313.9M+5.4%	$297.7M+8.8%	$273.6M+15.3%	$237.2M
SG&A Expenses	$73.8M	$71.2M+18.5%	$60.1M-9.8%	$66.7M+21.7%	$54.8M+14.1%	$48.0M-14.7%	$56.3M+18.2%	$47.6M-1.3%	$48.3M+14.3%	$42.2M-1.8%	$43.0M-15.5%	$50.9M+7.4%	$47.3M+1.1%	$46.8M+18.7%	$39.4M+12.0%	$35.2M
Operating Income	$192.1M	$177.7M+2.8%	$172.9M+5.1%	$164.5M-23.8%	$215.9M-17.1%	$260.4M+173.9%	$95.1M-40.6%	$160.1M+8.9%	$147.0M-5.0%	$154.7M+14.2%	$135.5M+6.2%	$127.5M+4.6%	$121.9M+14.7%	$106.3M+10.3%	$96.4M+10.8%	$87.0M
EBITDA	N/A	$187.5M+2.9%	$182.2M+8.1%	$168.6M-23.5%	$220.3M-16.7%	$264.5M+165.2%	$99.7M-39.4%	$164.5M+8.7%	$151.4M-4.8%	$159.0M+13.8%	$139.7M+6.3%	$131.4M+3.9%	$126.5M+13.1%	$111.9M+9.8%	$101.9M+10.8%	$92.0M
Income Tax	N/A	N/A	$46.7M+7.1%	$43.6M-7.9%	$47.4M-15.0%	$55.8M+206.2%	$18.2M-55.1%	$40.6M+18.4%	$34.3M-49.6%	$67.9M+34.2%	$50.6M+4.5%	$48.4M+4.6%	$46.3M+12.6%	$41.1M+12.9%	$36.4M+11.7%	$32.6M
Net Income	$168.3M	$153.2M+1.3%	$151.3M+17.2%	$129.0M-24.6%	$171.0M-19.1%	$211.4M+176.0%	$76.6M-43.1%	$134.6M+18.2%	$113.9M+23.9%	$91.9M-1.1%	$92.9M+44.0%	$64.6M-14.5%	$75.5M+10.9%	$68.1M+3.0%	$66.1M+21.7%	$54.3M
EPS (Basic)	N/A	$2.99-0.3%	$3.00+14.5%	$2.62-25.4%	$3.51-19.9%	$4.38+173.7%	$1.60-43.9%	$2.85+17.3%	$2.43+22.7%	$1.98-2.0%	$2.02+42.3%	$1.42-16.0%	$1.69+9.7%	$1.54+2.0%	$1.51+19.8%	$1.26
EPS (Diluted)	$3.25	$2.970.0%	$2.97+14.2%	$2.60-25.1%	$3.47-19.5%	$4.31+174.5%	$1.57-43.7%	$2.79+16.3%	$2.40+22.4%	$1.96-2.0%	$2.00+41.8%	$1.41-14.5%	$1.65+9.3%	$1.51+1.3%	$1.49+21.1%	$1.23
Diluted Shares (Avg)	N/A	52M+1.2%	51M+2.8%	50M+0.5%	49M+0.4%	49M+0.9%	49M+0.8%	48M+1.9%	47M+0.9%	47M+1.2%	46M+1.2%	46M+0.6%	46M+1.2%	45M+1.4%	44M+1.2%	44M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$152.7M+12.2%	$145.6M+8.3%	$143.8M+2.9%	$141.7M+6.4%	$136.1M+11.8%	$134.5M+9.6%	$139.8M+17.3%	$133.2M+7.7%
SG&A Expenses	$19.0M+4.8%	$18.9M+10.1%	$19.2M+21.7%	$16.8M+12.8%	$18.1M+23.1%	$17.2M+16.1%	$15.8M-8.8%	$14.9M-4.3%
Operating Income	$52.8M+21.8%	$50.1M+10.9%	$40.3M-18.3%	$48.9M+9.0%	$43.3M+12.8%	$45.2M+12.3%	$49.3M+30.3%	$44.9M+9.8%
EBITDA	$55.4M+21.2%	$52.7M+10.8%	$42.8M-17.2%	$51.4M+8.9%	$45.7M+12.4%	$47.6M+11.8%	$51.8M+31.6%	$47.2M+13.3%
Income Tax	$16.4M+36.4%	N/A	N/A	N/A	$12.1M+10.9%	N/A	$12.7M+6.8%	$12.3M+16.6%
Net Income	$49.3M+33.9%	$42.4M+6.5%	$34.9M-23.9%	$41.7M+5.2%	$36.8M+16.0%	$39.8M+17.0%	$45.8M+53.7%	$39.7M+23.4%
EPS (Basic)	$0.96+33.3%	$0.82+5.1%	$0.68-24.4%	$0.81+3.8%	$0.72+14.3%	$0.78+13.0%	$0.90+47.5%	$0.78+20.0%
EPS (Diluted)	$0.95+31.9%	$0.82+6.5%	$0.67-24.7%	$0.81+5.2%	$0.72+14.3%	$0.77+13.2%	$0.89+48.3%	$0.77+18.5%
Diluted Shares (Avg)	52M+0.8%	52M+0.3%	N/A	52M+0.3%	51M+1.4%	51M+3.2%	N/A	51M+3.6%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Interest Expense.

CNS Balance Sheet

CNS quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$876.7M+7.9%	$812.4M+10.3%	$736.6M+9.4%	$673.4M+36.7%	$492.7M+41.4%	$348.5M-13.4%	$402.4M-16.3%	$481.0M+17.3%	$410.1M+22.9%	$333.7M+9.3%	$305.3M+8.8%	$280.7M+2.1%	$274.9M-18.5%	$337.3M+17.8%	$286.2M
Cash & Equivalents	$145.5M-20.5%	$183.0M-2.4%	$187.4M-24.2%	$247.4M+34.2%	$184.4M+347.2%	$41.2M-59.3%	$101.4M+9.3%	$92.7M-52.1%	$193.5M+5.6%	$183.2M+28.4%	$142.7M+14.2%	$124.9M-31.8%	$183.2M+92.0%	$95.4M-25.4%	$127.8M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	N/A	$74.4M	N/A	N/A	N/A	N/A	$59.1M+17.3%	$50.4M-6.4%	$53.9M+16.3%	$46.3M+3.9%	$44.6M+2.7%	$43.4M+6.1%	$40.9M-7.9%	$44.4M+12.1%	$39.6M
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	$18.8M+7.3%	$17.5M-3.5%	$18.1M+1.9%	$17.8M-3.5%	$18.4M-4.2%	$19.2M+5.1%	$18.3M-1.0%	$18.5M-2.8%	$19.0M+7.6%	$17.7M-1.6%	$18.0M-6.0%	$19.1M-7.5%	$20.7M+2.7%	$20.1M+0.9%	$19.9M
Total Liabilities	$242.8M+2.3%	$237.5M-2.6%	$243.9M-1.0%	$246.4M+66.1%	$148.4M+20.1%	$123.5M-8.7%	$135.3M-47.6%	$258.4M+197.7%	$86.8M+29.4%	$67.1M+7.8%	$62.2M+19.3%	$52.1M+1.9%	$51.2M-24.3%	$67.5M+32.6%	$50.9M
Total Equity	$562.0M+9.8%	$511.7M+34.2%	$381.2M+12.9%	$337.6M+32.3%	$255.2M+46.5%	$174.2M-18.5%	$213.7M-4.0%	$222.6M-19.2%	$275.5M+3.7%	$265.8M+14.7%	$231.8M+1.7%	$228.0M+2.0%	$223.6M+3.2%	$216.6M-6.0%	$230.5M
Retained Earnings	-$105.8M+18.2%	-$129.3M+18.2%	-$158.2M+7.7%	-$171.4M+26.1%	-$232.0M+20.4%	-$291.5M-20.2%	-$242.5M-16.3%	-$208.4M-51.0%	-$138.0M-7.8%	-$128.0M+13.6%	-$148.1M-3.7%	-$142.8M-8.7%	-$131.4M-11.4%	-$117.9M-41.9%	-$83.1M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$901.0M+20.0%	$854.7M+2.4%	$876.7M+7.9%	$801.6M+10.1%	$751.0M-4.2%	$834.9M+22.6%	$812.4M+10.3%	$727.8M+8.0%
Cash & Equivalents	$59.2M-38.0%	$53.1M-18.6%	$145.5M-20.5%	$98.1M-7.9%	$95.4M-21.8%	$65.2M-34.5%	$183.0M-2.4%	$106.5M-20.0%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Accounts Receivable	N/A	N/A	N/A	$68.3M	N/A	N/A	$74.4M	N/A
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Goodwill	N/A	N/A	$18.8M+7.3%	N/A	N/A	N/A	$17.5M-3.5%	N/A
Total Liabilities	$205.6M-1.5%	$187.8M-3.0%	$242.8M+2.3%	$222.4M+3.3%	$208.7M+4.5%	$193.5M-6.0%	$237.5M-2.6%	$215.2M-1.1%
Total Equity	$589.4M+11.5%	$563.4M+11.0%	$562.0M+9.8%	$550.3M+12.1%	$528.5M+14.1%	$507.7M+34.0%	$511.7M+34.2%	$491.0M+33.9%
Retained Earnings	-$85.1M+27.6%	-$98.9M+18.9%	-$105.8M+18.2%	-$108.3M+25.0%	-$117.5M+23.4%	-$121.9M+21.0%	-$129.3M+18.2%	-$144.4M+9.2%

Not reported in any period shown, so not listed: Current Assets, Inventory, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

CNS Cash Flow Statement

CNS quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$72.2M	-$120.4M-224.6%	$96.7M-43.8%	$172.0M+178.8%	$61.7M-74.6%	$242.9M+172.4%	$89.2M-36.9%	$141.4M+94.8%	$72.6M+13.0%	$64.3M-44.1%	$115.0M+28.0%	$89.8M+64.5%	$54.6M-28.1%	$75.9M+273.0%	$20.3M-71.9%	$72.4M
Depreciation & Amortization	N/A	$9.8M+5.4%	$9.3M+126.3%	$4.1M-6.3%	$4.4M+7.1%	$4.1M-12.0%	$4.7M+5.8%	$4.4M+0.4%	$4.4M+3.5%	$4.2M+1.8%	$4.2M+8.6%	$3.8M-15.6%	$4.5M-17.8%	$5.5M+0.8%	$5.5M+10.2%	$5.0M
Stock-Based Compensation	N/A	$46.0M-12.1%	$52.3M+17.6%	$44.5M-9.9%	$49.4M+22.0%	$40.5M+37.9%	$29.3M+5.5%	$27.8M+12.9%	$24.6M+10.1%	$22.4M+1.1%	$22.1M-2.5%	$22.7M-9.0%	$24.9M+15.7%	$21.5M+22.6%	$17.6M-6.0%	$18.7M
Capital Expenditures	N/A	$6.0M-48.7%	$11.7M-79.6%	$57.0M+1249.4%	$4.2M+56.7%	$2.7M+7.7%	$2.5M-9.1%	$2.8M-20.7%	$3.5M+7.0%	$3.2M-68.2%	$10.2M+319.6%	$2.4M-59.0%	$5.9M-5.0%	$6.2M+85.4%	$3.4M+14.8%	$2.9M
Free Cash Flow	N/A	-$126.4M-248.7%	$85.0M-26.0%	$115.0M+100.1%	$57.5M-76.1%	$240.2M+177.1%	$86.7M-37.5%	$138.7M+100.6%	$69.1M+13.3%	$61.0M-41.8%	$104.8M+19.9%	$87.4M+79.5%	$48.7M-30.1%	$69.6M+310.1%	$17.0M-75.6%	$69.5M
Investing Cash Flow	-$56.0M	$8.4M+107.0%	-$119.7M-4.3%	-$114.8M-3917.4%	-$2.9M-106.0%	$47.6M+2792.0%	-$1.8M-104.9%	$35.9M+167.6%	-$53.2M-1031.8%	$5.7M+97.0%	$2.9M+630.0%	$397K-96.0%	$9.8M-45.4%	$18.0M+634.4%	$2.5M+180.8%	-$3.0M
Financing Cash Flow	-$50.0M	$73.8M+306.4%	$18.2M+115.3%	-$119.1M-1426.5%	$9.0M+106.2%	-$145.4M+2.3%	-$148.9M+12.5%	-$170.1M-44.0%	-$118.1M-95.5%	-$60.4M+18.9%	-$74.5M-4.8%	-$71.1M-8.4%	-$65.6M-6.3%	-$61.8M-11.0%	-$55.7M+28.2%	-$77.5M
Dividends Paid	$132.6M	$126.9M+6.5%	$119.2M+6.0%	$112.4M+4.7%	$107.4M-27.2%	$147.6M+20.5%	$122.5M-24.7%	$162.7M-9.0%	$178.9M+81.9%	$98.3M+38.8%	$70.8M+3.9%	$68.2M-19.1%	$84.2M+5.7%	$79.7M-18.0%	$97.2M+40.6%	$69.1M
Share Buybacks	$19.1M	$28.4M+34.6%	$21.1M-2.0%	$21.5M-19.7%	$26.8M+18.7%	$22.6M-12.9%	$25.9M+149.2%	$10.4M-1.8%	$10.6M+16.0%	$9.1M+13.7%	$8.0M-58.2%	$19.2M+64.1%	$11.7M+47.2%	$8.0M-6.2%	$8.5M+27.6%	$6.6M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$67.4M+199.6%	-$51.4M+52.9%	$1.1M-97.0%	$55.1M+115.0%	-$67.6M-315.6%	-$108.9M-2340.3%	$34.8M-40.5%	$25.6M-65.7%
Depreciation & Amortization	$2.6M+9.7%	$2.6M+9.2%	$2.5M+4.5%	$2.5M+7.6%	$2.4M+4.7%	$2.4M+4.6%	$2.4M+64.2%	$2.3M+192.3%
Stock-Based Compensation	N/A	$10.8M-5.1%	N/A	N/A	N/A	$11.4M-12.5%	N/A	N/A
Capital Expenditures	N/A	N/A	$282K-83.2%	$2.5M+76.7%	$2.1M-49.7%	$1.1M-75.2%	$1.7M-84.5%	$1.4M-94.6%
Free Cash Flow	N/A	N/A	$776K-97.7%	$52.6M+117.2%	-$69.8M-357.1%	-$110.0M-20588.5%	$33.1M-30.5%	$24.2M-50.2%
Investing Cash Flow	-$35.1M-1485.1%	-$24.8M-1340.0%	$39.1M+69.1%	-$35.3M+9.8%	$2.5M+103.4%	$2.0M+106.8%	$23.1M+74.3%	-$39.1M+59.6%
Financing Cash Flow	-$26.9M-128.7%	-$13.7M-29.5%	$7.6M-42.1%	-$17.0M-577.7%	$93.8M+42.6%	-$10.5M+83.6%	$13.1M+165.9%	$3.6M+116.1%
Dividends Paid	$34.5M+8.9%	$34.5M+8.9%	$31.8M+5.9%	$31.7M+5.9%	$31.7M+6.1%	$31.7M+8.2%	$30.0M+6.8%	$30.0M+6.5%
Share Buybacks	$394K-36.6%	$16.9M-34.9%	$1.6M+1.3%	$258K+279.4%	$621K+363.4%	$26.0M+34.2%	$1.5M+79.5%	$68K+36.0%

CNS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

CNS quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Margin	32.0%-1.5pp	33.4%-0.2pp	33.6%-4.5pp	38.1%-6.5pp	44.6%+22.4pp	22.2%-16.8pp	39.0%+0.4pp	38.6%-2.3pp	40.9%+2.1pp	38.7%-0.1pp	38.8%0.0pp	38.8%+3.1pp	35.7%+0.5pp	35.3%-1.4pp	36.7%
Net Margin	27.6%-1.7pp	29.2%+2.9pp	26.4%-3.8pp	30.2%-6.0pp	36.2%+18.3pp	17.9%-14.9pp	32.8%+2.9pp	29.9%+5.6pp	24.3%-2.3pp	26.6%+6.9pp	19.6%-4.4pp	24.1%+1.2pp	22.9%-1.3pp	24.2%+1.3pp	22.9%
Return on Equity	27.3%-2.3pp	29.6%-4.3pp	33.9%-16.8pp	50.7%-32.2pp	82.8%+38.9pp	44.0%-19.0pp	63.0%+11.8pp	51.2%+17.8pp	33.4%-1.6pp	35.0%+7.1pp	27.9%-5.3pp	33.1%+2.6pp	30.5%-0.1pp	30.5%+7.0pp	23.6%
Return on Assets	17.5%-1.1pp	18.6%+1.1pp	17.5%-7.9pp	25.4%-17.5pp	42.9%+20.9pp	22.0%-11.5pp	33.5%+9.8pp	23.7%+1.3pp	22.4%-5.4pp	27.9%+6.7pp	21.1%-5.8pp	26.9%+2.1pp	24.8%+5.2pp	19.6%+0.6pp	19.0%
Debt-to-Equity	0.430.0x	0.46-0.2x	0.64-0.1x	0.73+0.1x	0.58-0.1x	0.71+0.1x	0.63-0.5x	1.16+0.8x	0.32+0.1x	0.250.0x	0.270.0x	0.230.0x	0.23-0.1x	0.31+0.1x	0.22
Asset Turnover	0.630.0x	0.640.0x	0.66-0.2x	0.84-0.3x	1.190.0x	1.23+0.2x	1.02+0.2x	0.79-0.1x	0.92-0.1x	1.050.0x	1.080.0x	1.120.0x	1.08+0.3x	0.810.0x	0.83
FCF Margin	-22.7%-39.2pp	16.4%-7.0pp	23.5%+13.3pp	10.1%-31.0pp	41.1%+20.9pp	20.3%-13.5pp	33.8%+15.6pp	18.1%+2.0pp	16.1%-13.8pp	29.9%+3.4pp	26.6%+11.1pp	15.5%-7.9pp	23.4%+17.2pp	6.2%-23.1pp	29.3%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Margin	34.5%+2.7pp	34.4%+0.8pp	28.0%-7.3pp	34.5%+0.8pp	31.8%+0.3pp	33.6%+0.8pp	35.3%+3.5pp	33.7%+0.7pp
Net Margin	32.3%+5.2pp	29.1%-0.5pp	24.3%-8.5pp	29.4%-0.4pp	27.1%+1.0pp	29.6%+1.9pp	32.8%+7.8pp	29.8%+3.8pp
Return on Equity	8.4%+1.4pp	7.5%-0.3pp	6.2%-2.7pp	7.6%-0.5pp	7.0%+0.1pp	7.8%-1.1pp	8.9%+1.1pp	8.1%-0.7pp
Return on Assets	5.5%+0.6pp	5.0%+0.2pp	4.0%-1.7pp	5.2%-0.3pp	4.9%+0.9pp	4.8%-0.2pp	5.6%+1.6pp	5.5%+0.7pp
Debt-to-Equity	0.350.0x	0.330.0x	0.430.0x	0.400.0x	0.390.0x	0.38-0.2x	0.46-0.2x	0.44-0.2x
Asset Turnover	0.170.0x	0.170.0x	0.160.0x	0.180.0x	0.180.0x	0.160.0x	0.170.0x	0.180.0x
FCF Margin	N/A	N/A	0.5%-23.2pp	37.1%+18.9pp	-51.2%-73.5pp	-81.8%-82.3pp	23.7%-16.3pp	18.2%-21.1pp

Not reported in any period shown, so not listed: Gross Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Cohen & Steers Inc. CNS	FY2025	$556.1M	$153.2M	27.6%	$3.7B	39/100
AllianceBernstein Holding, L.P. AB	FY2025	N/A	$299.8M	N/A	$3.3B	—
ARTISAN PARTNERS ASSET MANAGEMENT INC. APAM	FY2025	$1.2B	$290.3M	24.3%	$2.4B	57/100
Federated Hermes, Inc. FHI	FY2025	$1.8B	$403.3M	22.4%	$4.2B	81/100
Hercules Capital, Inc. HTGC	FY2025	$507.9M	$339.7M	66.9%	$3.1B	19/100

Where Cohen & Steers Inc. Ranks

Frequently Asked Questions

What is Cohen & Steers Inc.'s annual revenue?

Cohen & Steers Inc. (CNS) reported $556.1M in total revenue for fiscal year 2025. This represents a 7.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Cohen & Steers Inc.'s revenue growing?

Cohen & Steers Inc. (CNS) revenue grew by 7.5% year-over-year, from $517.4M to $556.1M in fiscal year 2025.

Is Cohen & Steers Inc. profitable?

Yes, Cohen & Steers Inc. (CNS) reported a net income of $153.2M in fiscal year 2025, with a net profit margin of 27.6%.

What is Cohen & Steers Inc.'s EBITDA?

Cohen & Steers Inc. (CNS) had EBITDA of $187.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Cohen & Steers Inc.'s operating margin?

Cohen & Steers Inc. (CNS) had an operating margin of 32.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Cohen & Steers Inc.'s net profit margin?

Cohen & Steers Inc. (CNS) had a net profit margin of 27.6% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Cohen & Steers Inc. pay dividends?

Yes, Cohen & Steers Inc. (CNS) paid $2.48 per share in dividends during fiscal year 2025.

What is Cohen & Steers Inc.'s return on equity (ROE)?

Cohen & Steers Inc. (CNS) has a return on equity of 27.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Cohen & Steers Inc.'s free cash flow?

Cohen & Steers Inc. (CNS) recorded an outflow of $126.4M in free cash flow during fiscal year 2025. This represents a -248.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Cohen & Steers Inc.'s operating cash flow?

Cohen & Steers Inc. (CNS) recorded an outflow of $120.4M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Cohen & Steers Inc.'s total assets?

Cohen & Steers Inc. (CNS) had $876.7M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Cohen & Steers Inc.'s capital expenditures?

Cohen & Steers Inc. (CNS) invested $6.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Cohen & Steers Inc. buy back shares?

Yes, Cohen & Steers Inc. (CNS) spent $28.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Cohen & Steers Inc. have outstanding?

Cohen & Steers Inc. (CNS) had 51M shares outstanding as of fiscal year 2025.

What is Cohen & Steers Inc.'s debt-to-equity ratio?

Cohen & Steers Inc. (CNS) had a debt-to-equity ratio of 0.43 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Cohen & Steers Inc.'s return on assets (ROA)?

Cohen & Steers Inc. (CNS) had a return on assets of 17.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Cohen & Steers Inc.'s P/E ratio?

Cohen & Steers Inc. (CNS) trades at 22.2x earnings, its market capitalization divided by net income of $168.3M net income, trailing 12 months to June 30, 2026. The market capitalization is $3.7B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Cohen & Steers Inc.'s price-to-sales ratio?

Cohen & Steers Inc. (CNS) trades at 6.4x sales, its market capitalization divided by revenue of $583.9M revenue, trailing 12 months to June 30, 2026. The market capitalization is $3.7B as of Oct 6, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Cohen & Steers Inc.'s Piotroski F-Score?

Cohen & Steers Inc. (CNS) has a Piotroski F-Score of 1 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Cohen & Steers Inc.'s earnings high quality?

For every $1 of reported earnings, Cohen & Steers Inc. (CNS) used $0.79 of operating cash (-$120.4M OCF vs $153.2M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Cohen & Steers Inc.?

Cohen & Steers Inc. (CNS) scores 39 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.